THE ACELYRIN CLASS ACTION LAWSUIT: 4 Things investors need to know

If you suffered losses in ACELYRIN stock, contact ACELYRIN stock loss lawyer Timothy L. Miles about an ACELYRIN class action lawsuit

INTRODUCTION TO THE ACELYRIN CLASS ACTION LAWSUIT

​The ACELYRIN class action lawsuit seeks to represent purchasers or acquirers of ACELYRIN, Inc. (NASDAQ: SLRN) securities between May 4, 2023 and September 11, 2023 (the “Class Period”).  Captioned Aramouni v. ACELYRIN, Inc., No. 23-cv-09672 (C.D. Cal.), the ACELYRIN class action lawsuit charges ACELYRIN and certain of its top current and former executive officers with violations of the​​ Securities Exchange Act of 1934.
​​
If you suffered losses in ACELYRIN stock and wish to serve as lead plaintiff in the ACELYRIN class action lawsuit, please contact ACELYRIN Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at [email protected] or by submitting a contact form. Lead plaintiff motions for the ACELYRIN class action lawsuit must be filed with the court no later than January 16, 2024.

Read on to learn more about four things that ACELYRIN investors need to know about the ACELYRIN class action lawsuit.

ALLEGATIONS IN THE ACELYRIN LAWSUIT

ACELYRIN is a clinical biopharma company that focuses on developing and commercializing transformative medicines.  According to the ACELYRIN class action lawsuit, ACELYRIN’s lead product candidate is izokibep, which is currently in Part B of a Phase 2b/3 clinical trial for use in the treatment of moderate to severe Hidradenitis Suppurativa (“HS”).

The ACELYRIN class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) izokibep was less effective in treating HS than defendants had led investors to believe; (ii) accordingly, ACELYRIN overstated izokibep’s clinical and/or commercial prospects; and (iii) as a result, ACELYRIN also overstated its business prospects post-initial public offering. 

The ACELYRIN class action lawsuit further alleges that on September 11, 2023, ACELYRIN announced disappointing top-line results from Part B of the Phase 2b/3 trial evaluating izokibep for the treatment of moderate-to-severe HS.  Specifically, izokibep failed to show statistically significant reduction in abscesses and inflammatory nodules in patients as compared to placebo, the complaint alleges.  The ACELYRIN class action lawsuit alleges that on this news, the price of ACELYRIN stock fell more than 61% over two trading sessions. ​

WHAT ARE THE BENEFITS OF SERVING AS LEAD PLAINTIFF IN THE ACELYRIN CLASS ACTION LAWSUIT?

Serving as a Lead Plaintiff in the ACELYRIN class action lawsuit has several advantages and important benefits including:

• A Lead Plaintiff is able to negotiate more competitive attorney fees and reduce other litigation costs by actively monitoring the class counsel.
• Lead Plaintiff has the benefit of being able to manage the litigation primarily by overseeing and monitoring the progress of the action and the efforts of counsel, and being able to review and comment on important filings and other documents pertaining to the prosecution of the action.
• There is no financial risk in serving as a Lead Plaintiff because Lead Counsel advances all costs and expenses incurred in the prosecution of the case and will be reimbursed only if there is a successful settlement or judgment recovery on behalf of the class.
• Lead Plaintiff has the benefit of being involved and active in all negotiations relating to any settlement.
• Lead Plaintiffs that continue owning the stock of the defendant will enjoy the long-term benefits from governance reform resulting from the litigation. 

Thus, there are numerous benefits and other advantages to serving as lead plaintiff in a class action against ACELYRIN​ if you suffered losses in ACELYRIN stock. ​

HOW WAS THE CLASS PERIOD DETERMINED IN THE ACELYRIN CLASS ACTION LAWSUIT?

In a securities fraud class action, the class period refers to a period of time in which it is alleged the price of the company’s stock was artificially inflated due to false and misleading statements made by company executives.  The class period starts when the company makes an untrue statement of material fact about the company or fails to disclose a material fact necessary to render other statements not misleading.  The class period ends when the truth is revealed to the investing public through a corrective disclosure.  
 
In order to be a part of the class in the ACELYRIN​ class action lawsuit, you must have suffered losses in ACELYRIN stock by purchasing during the class period when it is alleged the price of the stock was artificially inflated to be included in the class action against ACELYRIN​​.  ​

HOW CAN AN ACELYRIN STOCK LOSS LAWYER HELP ME IF I SUFFERED LOSSES IN ACELYRIN STOCK?

​​​​An ACELYRIN stock loss Lawyer is well-versed in the complex laws that govern the securities industry and litigation and focuses on representing individual investors or funds who have been the victims of fraud or who have disputes with investment professionals such as the ACELYRIN​ class action lawsuit. Ordinary individual investors, including civil servants, teachers, nurses, and retirees, may need a securities lawyer. In most cases, they have lost money due to mistakes, incompetence, or fraud by an investment professional.

While FINRA, the SEC, and state securities regulators serve a vital role in protecting investors, they simply have too many individuals, firms, and market transactions to monitor to discover every act of fraud or negligence. Individual investors should consult with a securities lawyer if they have lost money due to fraud or stockbroker misconduct. 

Look for a securities lawyer with experience, high ethical standards, verifiable credentials, and a trustworthy reputation among his peers and the judiciary, as well as testimonials from previous clients and awards and recognitions.

One name that immediately pops up is nationally known and widely respected Nashville lawyer Timothy L. Miles, who has valuable experience and has received numerous awards, mostly due to his high ethical standards, and hard work ethic, including most recently being named a Top 25 Class action lawyer by the National Trial Lawyers Association, and has maintained an AV rating from Martindale-Hubble since 2014, was named a 2023 Top Rated Litigator and 2023 Top Rated Lawyer by Martindale-Hubble and ALM, and was recently named a 2023 Elite Lawyer of the South by Martindale-Hubble for the fifth year in a row, and was a recipient of Avvo Client’s Choice Award in 2021, in 2022 was featured in the Top 100 Lawyers Magazine and received the Lifetime Achievement Award by Premier Lawyers of America (2019–2021).

​This will most likely be the only call you need to make. (855) 846–6529 or [email protected]. 

CONTACT AN ACELYRIN STOCK LOSS LAWYER TODAY IF YOU SUFFERED LOSSES IN ACELYRIN STOCK ABOUT AN ACELYRIN CLASS ACTION LAWSUIT

If you suffered losses in ACELYRIN stock, contact ACELYRIN stock loss lawyer Timothy L. Miles today for a free case evaluation about an ACELYRIN lawsuit. This will most likely be the only call you need to make. (855) 846–6529 or [email protected]. ​

ACELYRIN stock loss lawyer Timothy L. Miles 

Nashville attorney Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles has dedicated his career to representing shareholders, employees, and consumers in complex class-action litigation. Whether serving as lead, co-lead, or liaison counsel, Mr. Miles has helped recover hundreds of millions of dollars for defrauded investors, shaped precedent-setting decisions, and delivered real corporate governance reforms. Judges and peers have repeatedly recognized Mr. Miles relentless advocacy for the underdog, as well as his unbendable ethical standards. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator, and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, Class Action:  Class Action: Top 100 National Trial Lawyers, National Trial Lawyers Association (2023), a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019); a Top Rated Litigator by Martindale-Hubbell® and ALM  (2019-2022); America's Most Honored Lawyers 2020; Top 1% by America's Most Honored (2020-2022).  Mr. Miles has published over three hundred articles on various issues of the law, including class actions, whistleblower cases, products liability, civil procedure, derivative actions, corporate takeover litigation, corporate formation, mass torts, dangerous drugs, and more.  Please visit our website or Resources center and call for free anytime.

CONTACT                                                      
The Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
300 Centerview Dr., #247
Brentwood, TN 37027
Phone: (855) 846-6529